BULLETIN V2026-3169
HEMOSTEMIX INC. ("HEM")
BULLETIN TYPE: Private Placement-Non-Brokered
BULLETIN DATE: October 7, 2026
TSX Venture Tier 2 Company
Financing Type: Non-Brokered Private Placement
Gross Proceeds: $682,250
Offering: 13,645,000 Units with 6,822,500 warrants attached
Offering Price: $0.05 per Unit
Warrant Exercise Terms: $0.12 per Listed Share for a 2-year period, subject to an acceleration right.
Commissions in Securities:
Shares
Warrants
Finders (Aggregate)
NIL
683,600
Commission Terms: Each non-transferable warrant is exercisable at $0.06 for a 2-year period, subject to an acceleration right.
Disclosure: Refer to the company's news release(s) dated June 17, 2026, June 26, 2026, July 30, 2026 and September 23, 2026.
_______________________________________
|
|
